Byron Lawson

Companies

• HTG MOLECULAR DIAGNOSTICS, INCSVP/Chief Commercial Officer Feb 3, 2020 to Dec 13, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• HMHTG MOLECULAR DIAGNOSTICS, INC6,033 shares²Dec 9, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Dec 9, 2022Granted 1,000 shares at $0.43 of HTG MOLECULAR DIAGNOSTICS, INC²
• Jun 30, 2022Shares withheld for tax 23 shares at $1.03 of HTG MOLECULAR DIAGNOSTICS, INC³
• Jun 10, 2022Granted 1,000 shares at $0.48 of HTG MOLECULAR DIAGNOSTICS, INC⁴
• Mar 31, 2022Shares withheld for tax 23 shares at $1.39 of HTG MOLECULAR DIAGNOSTICS, INC⁵
• Dec 31, 2021Shares withheld for tax 24 shares at $5.42 of HTG MOLECULAR DIAGNOSTICS, INC⁶
• Dec 10, 2021Granted 896 shares at $3.56 of HTG MOLECULAR DIAGNOSTICS, INC⁷
• Sep 30, 2021Shares withheld for tax 24 shares at $5.71 of HTG MOLECULAR DIAGNOSTICS, INC⁸